Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...
Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F.
While Donald Trump may be "thrilled" to nominate Robert F Kennedy Jr to head America's health agency, experts say he's "completely unqualified" for the job. Here's why.